Wenzhou Kangning Hospital Co Ltd

Wenzhou Kangning Hospital Co Ltd maintains a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it can cover short-term obligations but with limited buffer. Free cash flow is negative at -121.8 million CNY, reflecting capital expenditure outpacing operating cash flow. Profitability metrics show a return on equity of 4.58% and a return on assets of 1.8%, both below the industry median for Healthcare Facilities & Services. The company's operating income of 84.8 million CNY and net income of 54.4 million CNY indicate a relatively narrow margin structure, which may limit its ability to absorb cost increases or invest in growth. The company's revenue is concentrated in its core healthcare operations, with no disclosed geographic diversification. The largest segment is the psychiatric and elderly healthcare services, which accounts for the majority of revenue. The other healthcare-related business, including medical device sales and social services, contributes a smaller but growing portion of total revenue. Outlook for the current fiscal year shows a projected revenue increase of 5.2%, driven by expansion in outpatient services and new facility openings. For the next fiscal year, the company anticipates a 7.8% growth in revenue, supported by continued investment in digital health infrastructure and expanded service offerings. Risk factors include a medium liquidity risk due to the negative net cash position after subtracting total debt. The company has a low dilution potential, with no recent share issuance or ATM programs disclosed. However, the negative free cash flow and high capital expenditure suggest potential pressure to raise additional capital in the near term. Recent events include the filing of the 2023 annual report, which disclosed plans for new facility construction and a strategic pivot toward digital health services. No material earnings call transcripts or regulatory actions were reported in the last quarter.